Click on image to view larger version.

Figure 4 Changes in left ventricular norepinephrine (NE) uptake-1 carrier site density, catecholaminergic fluorescence profile and tyrosine hydroxylase immunostained profile in sham animals and in animals with congestive heart failure (CHF). Symbols as in Figure 1.